Literature DB >> 34480740

Omentin-1 and its relationship with inflammatory factors in maternal plasma and visceral adipose tissue of women with gestational diabetes mellitus.

M I Peña-Cano1, J Valencia-Ortega2, E Morales-Ávila3, M F Díaz-Velázquez4, R Gómez-Díaz5, R Saucedo6.   

Abstract

PURPOSE: To investigate the association of omentin-1 and inflammatory factors in serum and visceral adipose tissue (VAT) of women with gestational diabetes mellitus (GDM) compared to normal pregnant (NP) subjects. Furthermore, to examine their correlation with maternal clinical characteristics.
METHODS: We compared 116 GDM women to 115 NP women, at the time of cesarean section. Circulating omentin-1 and pro-inflammatory (IL-1β, IL-6, TNF-α), and anti-inflammatory cytokines (IL-1RA, IL-10) were examined. Moreover, their mRNA expression in VAT, along with inflammatory factors involved in the NF-κB pathway (TLR2, TLR4, NF-κB, IKκB), were examined.
RESULTS: Circulating omentin-1 (p = 0.022) was lower and circulating IL-1-β, IL-1RA, as well as IL-10 (p = 0.005, p = 0.007, and p = 0.015, respectively), were higher in GDM compared to NP women. Omentin-1 correlated negatively with pre-pregnancy and gestational BMI, and HOMA-IR in all women, but was not associated with cytokines. TLR2, TLR4, IL-1β, IL-1RA, IL-6, IL-10 mRNA expression in VAT was lower in GDM compared with controls (p < 0.05 all). In multivariate analysis, BMI at delivery was significantly correlated to omentin-1 concentrations in all and NP subjects. In addition, omentin-1 expression was correlated to inflammatory gene expression in all, GDM and NP, women (p < 0.05 all).
CONCLUSION: Serum levels and VAT gene expression of omentin-1 are not independently linked to GDM; notwithstanding, GDM women have a VAT-altered inflammatory status. In addition, no systemic association between omentin-1 and inflammatory factors was found, whereas associations between their expression in all women were observed, indicating that expression of these adipokines is linked between them regardless of GDM.
© 2021. Italian Society of Endocrinology (SIE).

Entities:  

Keywords:  Cytokines; Gestational diabetes mellitus; Omentin-1; Visceral adipose tissue; mRNA expression

Mesh:

Substances:

Year:  2021        PMID: 34480740     DOI: 10.1007/s40618-021-01671-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells.

Authors:  Hideyuki Yamawaki; Junji Kuramoto; Satoshi Kameshima; Tatsuya Usui; Muneyoshi Okada; Yukio Hara
Journal:  Biochem Biophys Res Commun       Date:  2011-04-13       Impact factor: 3.575

Review 2.  Gestational diabetes mellitus.

Authors:  H David McIntyre; Patrick Catalano; Cuilin Zhang; Gernot Desoye; Elisabeth R Mathiesen; Peter Damm
Journal:  Nat Rev Dis Primers       Date:  2019-07-11       Impact factor: 52.329

3.  Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells.

Authors:  Kyosuke Kazama; Tatsuya Usui; Muneyoshi Okada; Yukio Hara; Hideyuki Yamawaki
Journal:  Eur J Pharmacol       Date:  2012-04-24       Impact factor: 4.432

4.  Omentin plasma levels and gene expression are decreased in obesity.

Authors:  Celia M de Souza Batista; Rong-Ze Yang; Mi-Jeong Lee; Nicole M Glynn; Dao-Zhan Yu; Jessica Pray; Kelechi Ndubuizu; Susheel Patil; Alan Schwartz; Mark Kligman; Susan K Fried; Da-Wei Gong; Alan R Shuldiner; Toni I Pollin; John C McLenithan
Journal:  Diabetes       Date:  2007-02-28       Impact factor: 9.461

Review 5.  Adipose Tissue-Derived Omentin-1 Function and Regulation.

Authors:  Takuya Watanabe; Kaho Watanabe-Kominato; Yui Takahashi; Miho Kojima; Rena Watanabe
Journal:  Compr Physiol       Date:  2017-06-18       Impact factor: 9.090

6.  Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.

Authors:  Rong-Ze Yang; Mi-Jeong Lee; Hong Hu; Jessica Pray; Hai-Bin Wu; Barbara C Hansen; Alan R Shuldiner; Susan K Fried; John C McLenithan; Da-Wei Gong
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-03-10       Impact factor: 4.310

7.  [Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus].

Authors:  Bao-Long Pan; Run-Mei Ma
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-08-20

Review 8.  Adipokines in gestational diabetes.

Authors:  Mathias Fasshauer; Matthias Blüher; Michael Stumvoll
Journal:  Lancet Diabetes Endocrinol       Date:  2013-12-30       Impact factor: 32.069

9.  Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus.

Authors:  Panayoula C Tsiotra; Panagiotis Halvatsiotis; Konstantinos Patsouras; Eirini Maratou; George Salamalekis; Sotirios A Raptis; George Dimitriadis; Eleni Boutati
Journal:  Peptides       Date:  2018-01-11       Impact factor: 3.750

10.  Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity.

Authors:  Gillian Barker; Ratana Lim; Harry M Georgiou; Martha Lappas
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more
  2 in total

Review 1.  New Insights into Adipokines in Gestational Diabetes Mellitus.

Authors:  Jorge Valencia-Ortega; Rebeca González-Reynoso; Edgar G Ramos-Martínez; Aldo Ferreira-Hermosillo; María I Peña-Cano; Enrique Morales-Ávila; Renata Saucedo
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

Review 2.  The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin.

Authors:  Han Na Jung; Chang Hee Jung
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.